Short Answer: DSIP is an experimental peptide originally studied for possible effects on deep sleep and sleep regulation, but scientists still do not fully understand how it works in the body or whether it produces reliable clinical benefits
FDA staff scientists had unanimously opposed every peptide being added to the list, citing a lack of solid clinical trial data, inconsistent recipes from batch to batch and the risk the compounds could trigger harmful immune reactions
Van den Heuvel, Vitamin B(12) in Relation to Oxidative Stress: A Systematic Review, Nutrients , vol
Theyve created something special, and Im already looking forward to my next visit
The cancelled Phase I trial was not buried by a regulator
It costs more as it is not so stable and is recommended for smokers and people with kidney problems